What can be gained by increasing our understanding of other gynecologic cancers or other parts of the female reproductive system? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and researchers who are well-known and well-respected experts in the field of gynecologic oncology. They review the proposals we receive for research funding — hundreds of … Continued
Auction Opens Soon Have you always wanted to own a piece of pop culture history? Cancer Gets Lost, an online charity auction, is opening its offerings this week, and all proceeds will benefit OCRA. You can get rare and signed items from hit shows and movies, and make an impact on the future of ovarian cancer treatment and care! Bid … Continued
From March 25-28, 2023, gynecologic cancer experts from around the world converged on Tampa, Florida to participate in the Annual Meeting on Women’s Cancer hosted by the Society of Gynecologic Oncology. The meeting was packed with educational and scientific sessions highlighting the latest in the care of patients with gynecologic cancers. Below are some highlights of … Continued
A new study, published in the Journal of Clinical Investigation and funded in part by OCRA, has found that mesothelial cells are a critical factor in ovarian cancer metastasis. High-grade serous ovarian cancer, the most common ovarian cancer subtype, is known to be aggressive, and is associated with the presence of ascites and widespread metastases … Continued
You may hear the terms “uterine cancer” and “endometrial cancer” used interchangeably. But uterine cancer is an umbrella term that includes two distinct cancer types — endometrial cancer and uterine sarcoma. When people talk about uterine cancer, they usually are referring to endometrial cancer, which is far more common than uterine sarcoma. Endometrial cancer, in … Continued
Endometriosis and endometrial cancer are often confused because the names of these two conditions sound so much alike. In fact, they are very different. Endometriosis is not cancer, and having endometriosis does not necessarily lead to endometrial cancer. Endometriosis can be very painful, but it is not lethal. What these two conditions do have in common is … Continued
Two OCRA Heroes are committed to pushing the limits of their physical endurance as a show of solidarity for our community this spring. Ethan Willey from Arizona and Mark Everitt from Connecticut will be taking on swimming, biking and running in order to complete a daunting 70.3 miles during two separate Half Ironman events — … Continued
Spring is officially here, and there’s so much to share — from a roundup on the impact of our risk and prevention campaign, to new ways to get involved and give back. Catch up below. Research Advocacy Patient Support Events Ways to Give Now is the perfect time to think about how charitable giving can … Continued
OCRA’s nationwide campaign promoting risk awareness and consideration of opportunistic salpingectomy, even for those at average risk, has resonated broadly, resulting in widespread media coverage that empowers individuals to take proactive steps in reducing their risk of ovarian cancer. “As the world’s leading ovarian cancer charity we knew we needed to shift the focus to … Continued
We hope you’re feeling the love from the teal community this week, and always. We’re just seven weeks into 2023 and there’s so much to share — new grantees, a new website, and a bold, new direction in the fight against ovarian cancer. Research Advocacy Patient Support Ways to Give Did you know there are three simple ways … Continued
Ovarian cancer is not a single disease, but rather a group of diseases classified by type and subtype. And while they all affect the ovaries, they are quite unique in terms of origin and prognosis. High-grade serous ovarian cancer (HGSOC) is the most common subtype, accounting for the majority of diagnoses, and typically involving a first-line … Continued
Audra Moran, President & CEO of OCRA, joined Katie Couric to explain important new developments around symptoms and early detection of ovarian cancer, and what this means for the future. “A seminal study came out about a year and a half ago that showed, unfortunately, that early detection of ovarian cancer, even in an earlier … Continued
Get email updates about research news, action alerts, and ways to join the fight.
